Categories Earnings, Health Care

Catabasis Pharmaceuticals (NASDAQ: CATB): Q4 2019 Earnings Snapshot

— Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) reported a net loss of $6.6 million or $0.55 per share for the fourth quarter of 2019, compared to a loss of $6.1 million or $0.85 per share last year. Analysts had forecast a loss of $0.61 per share.

— Being a development-stage biopharmaceutical company, Catabasis did nor record revenues in the December-quarter

— Research & Development expenses increased 16% year-over-year to $4.3 million during the three-month period

— At $2.5 million, selling, general and administrative expenses were up 4% from the year-ago period

— As of December 2019, cash, cash equivalents and short-term investments were $36.2 million, compared to $40.6 million as of September 2019

— Expects to fund operations through a potential NDA filing and into the third quarter of 2021, using available cash

— Expects to publish top results from the phase-3 PolarisDMD trial of edasalonexent, in Duchenne muscular dystrophy, in the fourth quarter of 2020

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

Key highlights from Deere & Company’s (DE) Q1 2025 earnings results

The Deere & Company (NYSE: DE) reported its first quarter 2025 earnings results today. Worldwide net sales and revenues decreased 30% year-over-year to $8.50 billion. Net income was $869 million, or $3.19 per

CSCO Earnings: A snapshot of Cisco’s Q2 2025 report

Cisco Systems Inc. (NASDAQ: CSCO), a leading manufacturer and distributor of data networking products, on Wednesday reported financial results for the second quarter of 2025. The San Jose-headquartered tech firm

What to look for when Walmart (WMT) reports Q4 results next week

Over the years, Walmart Inc. (NYSE: WMT) has consistently dominated the US grocery market, benefitting from lower prices and its wide product range across categories. After delivering an impressive performance

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top